Differentiation-inducing agents in the treatment of myelodysplastic syndromes
Kizaki, M.; Koeffler, H.P.
Seminars in Oncology 19(1): 95-105
1992
ISSN/ISBN: 0093-7754 PMID: 1371019 Document Number: 389479
Document emailed within 1 workday
Related Documents
Hatse, S.; De Clercq, E.; Balzarini, J. 1996: Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells Molecular Pharmacology 50(5): 1231-1242Cheson, B.D.; Zwiebel, J.A.; Dancey, J.; Murgo, A. 2000: Novel therapeutic agents for the treatment of myelodysplastic syndromes Seminars in Oncology 27(5): 560-577
Atallah, E.; Garcia-Manero, G. 2007: Use of hypomethylating agents in myelodysplastic syndromes Clinical Advances in Hematology and Oncology: H&o 5(7): 544-552
Pinto, A.; Zagonel, V.; Attadia, V.; Bullian, P.L.; Gattei, V.; Carbone, A.; Monfardini, S.; Colombatti, A. 1989: 5-Aza-2'-deoxycytidine as a differentiation inducer in acute myeloid leukaemias and myelodysplastic syndromes of the elderly Bone Marrow Transplantation 4(Suppl): 28-32
Yoshida, Y. 1991: Interferon gamma induces differentiation of cells from patients with myelodysplastic syndromes in vitro and in vivo Leukemia 5(9): 796-798
Li, L.-j.; Fu, R.; Wang, H.-q.; Yue, L.-z.; Liu, H.; Wang, J.; Wang, H.-l.; Ruan, E.-b.; Qu, W.; Liang, Y.; Wang, G.-j.; Wang, X.-m.; Liu, H.; Song, J.; Wu, Y.-h.; Xing, L.-m.; Guan, J.; Shao, Z.-h. 2010: Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances Zhonghua Yi Xue Za Zhi 90(10): 672-677
Seimiya, H.; Sawabe, T.; Inazawa, J.; Tsuruo, T. 1995: Cloning, expression and chromosomal localization of a novel gene for protein tyrosine phosphatase (PTP-U2) induced by various differentiation-inducing agents Oncogene 10(9): 1731-1738
Tohyama, K. 2012: Treatment of myelodysplastic syndromes (MDS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
Aviles, A.; García, L.D.; Romero, N.; Tripp, F.; González-Llaven, J. 1988: Treatment of myelodysplastic syndromes with danazol Archivos de Investigacion Medica 19(1): 73-77
Hellström-Lindberg, E. 1999: Treatment of adult myelodysplastic syndromes International Journal of Hematology 70(3): 141-154
Uzuka, Y.; Saito, Y. 1989: Bestatin treatment of patients with myelodysplastic syndromes Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(3 Part 1): 365-370
Neuwirtová, R.; Steruská, M.; Lukásová, M.; Háber, J.; Cieslar, P.; Kvasnicka, J. 1987: Personal experience in the treatment of the myelodysplastic syndromes Vnitrni Lekarstvi 33(5): 453-462
Bernasconi, C. 2001: Evidence-based approach to treatment of myelodysplastic syndromes Haematologica 86(9): 897-899
Rose, C.; Wattel, E.; Bastion, Y.; Berger, E.; Bauters, F.; Coiffier, B.; Fenaux, P. 1994: Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases Leukemia 8(9): 1458-1462
Silverman, L.R.; Holland, J.F.; Weinberg, R.S.; Alter, B.P.; Davis, R.B.; Ellison, R.R.; Demakos, E.P.; Cornell, C.J.; Carey, R.W.; Schiffer, C. 1993: Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes Leukemia 7(Suppl 1): 21-29
García Marco, J.; Miguel Sosa, A.; García Conde, J.; Miguel García, A.; Arbona, C.; Escrig, V.; Benet, I.; Navarro, I.; Ruiz, A.; Carbonell, F. 1994: Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes Sangre 39(4): 241-244
Gałeza-Obrepalska, B.; Dwilewicz-Trojaczek, J.; Paszkowska, M.; Kuratowska, Z. 1996: Preliminary results of erythropoietin treatment of anemia in myelodysplastic syndromes and chronic lymphocytic leukemia Polski Tygodnik Lekarski 51(19-22): 285-288
Ganser, A.; Ottmann, O.G.; Seipelt, G.; Lindemann, A.; Hess, U.; Geissler, G.; Maurer, A.; Frisch, J.; Schulz, G.; Mertelsmann, R. 1993: Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes Leukemia 7(5): 696-701
Januszewicz, E.H.; Firkin, F.C. 1988: Differentiation in acute myeloid leukemia and myelodysplastic disorders. Is differentiation-induction therapy possible? Australian and New Zealand Journal of Medicine 18(5): 705-711
Gerhartz, H.H.; Visani, G.; Delmer, A.; Zwierzina, H.; Ribeiro, M.; Jacobs, A.; Marcus, R.; Baumelou, M.; Fière, D.; Labar, B. 1989: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group Bone Marrow Transplantation 4(Suppl 3): 36-37